Ebola Virus

  • Emily RoseEmail author


Infection with the Ebola virus is an important condition to recognize as it is both highly contagious and has a significant associated morbidity and mortality rate. This chapter highlights the classic and atypical features of Ebola virus, details the symptom course, and emphasizes key diagnostic clues to the diagnosis of Ebola infection. Management of an acute infection is reviewed along with appropriate quarantine and the use of personal protective equipment in the care of infectious patients. Complications and risk of exposure and transmission are also discussed.


Ebola virus Marburg virus Hemorrhagic fever Mucocutaneous hemorrhage Personal protective equipment 


  1. 1.
    Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377(9768):849–62.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Baseler L, Chertow DS, Johnson KM, Feldmann H, Morens DM. The pathogenesis of Ebola virus disease. Annu Rev Pathol. 2017;12:387–418.CrossRefPubMedGoogle Scholar
  3. 3.
    Aylward B, Barboza P, Bawo L, et al. Ebola virus disease in West Africa – the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371(16):1481–95.CrossRefPubMedGoogle Scholar
  4. 4.
    Bray M, Murphy FA. Filovirus research: knowledge expands to meet a growing threat. J Infect Dis. 2007;196(Suppl 2):S438–43.CrossRefPubMedGoogle Scholar
  5. 5.
    World Health Organization, Factsheet on Ebola. Accessed 8/5/2017.
  6. 6.
    Centers for Disease Control and Prevention. Accessed 8/5/2017.
  7. 7.
    Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis. 2011;204(Suppl 3):S810–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis. 1999;179(Suppl 1):S1–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa – clinical manifestations and management. N Engl J Med. 2014;371(22):2054–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015;372(1):40–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Hunt L, Gupta-Wright A, Simms V, et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis. 2015;15(11):1292–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Akerlund E, Prescott J, Tampellini L. Shedding of Ebola virus in an asymptomatic pregnant woman. N Engl J Med. 2015;372(25):2467–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Dietz PM, Jambai A, Paweska JT, Yoti Z, Ksiazek TG. Epidemiology and risk factors for Ebola virus disease in Sierra Leone-23 May 2014 to 31 January 2015. Clin Infect Dis. 2015;61(11):1648–54.PubMedGoogle Scholar
  14. 14.
    Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014;371(22):2092–100.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    West TE, von Saint Andre-von Arnim A. Clinical presentation and management of severe Ebola virus disease. Ann Am Thorac Soc. 2014;11(9):1341–50.CrossRefPubMedGoogle Scholar
  16. 16.
    Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med. 2014;371(25):2394–401.CrossRefPubMedGoogle Scholar
  17. 17.
    de Greslan T, Billhot M, Rousseau C, et al. Ebola virus-related encephalitis. Clin Infect Dis. 2016;63(8):1076–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Jacobs M, Rodger A, Bell DJ, et al. Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet. 2016;388(10043):498–503.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Ebola virus disease update – West Africa. Accessed 8/5/2017.
  20. 20.
    Heymann DL, Chen L, Takemi K, et al. Global health security: the wider lessons from the west African Ebola virus disease epidemic. Lancet. 2015;385(9980):1884–901.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Heffernan RT, Pambo B, Hatchett RJ, Leman PA, Swanepoel R, Ryder RW. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooue-Ivindo region, Northeastern Gabon, 1997. J Infect Dis. 2005;191(6):964–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet. 2000;355(9222):2210–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Dean NE, Halloran ME, Yang Y, Longini IM. Transmissibility and pathogenicity of Ebola virus: a systematic review and meta-analysis of household secondary attack rate and asymptomatic infection. Clin Infect Dis. 2016;62(10):1277–86.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Mattia JG, Vandy MJ, Chang JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis. 2016;16(3):331–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Baggi FM, Taybi A, Kurth A, et al. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014. Euro Surveill. 2014;19(49):20983.CrossRefPubMedGoogle Scholar
  26. 26.
    Center for Disease Control and Prevention. Accessed 8/5/2017.
  27. 27.
    Parra JM, Salmeron OJ, Velasco M. The first case of Ebola virus disease acquired outside Africa. N Engl J Med. 2014;371(25):2439–40.CrossRefPubMedGoogle Scholar
  28. 28.
    Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med. 2014;371(25):2402–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Centers for Disease Control and Infection. Accessed 8/30/2017.
  30. 30.
    Uyeki TM, Mehta AK, Davey RT Jr, et al. Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med. 2016;374(7):636–46.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Clark DV, Kibuuka H, Millard M, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis. 2015;15(8):905–12.CrossRefPubMedGoogle Scholar
  32. 32.
    Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis. 1999;179(Suppl 1):S28–35.CrossRefPubMedGoogle Scholar
  33. 33.
    Kibadi K, Mupapa K, Kuvula K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis. 1999;179(Suppl 1):S13–4.CrossRefPubMedGoogle Scholar
  34. 34.
    Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med. 2015;372(25):2423–7.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med. 2015;373(25):2448–54.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Purpura LJ, Soka M, Baller A, et al. Implementation of a National Semen Testing and counseling program for male Ebola survivors – Liberia, 2015-2016. MMWR Morb Mortal Wkly Rep. 2016;65(36):963–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Emergency MedicineKeck School of Medicine of the University of Southern California, Los Angeles County + USC Medical CenterLos AngelesUSA

Personalised recommendations